Trademark Overview
On Thursday, October 16, 2025, a trademark application was filed for BELWAYO with the United States Patent and Trademark Office. The USPTO has given the BELWAYO trademark a serial number of 99446997. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, December 18, 2025. This trademark is owned by Glaxo Group Limited. The BELWAYO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives